In this guide
The growth-hormone axis, briefly
The peptides most studied in this category don't add growth hormone from the outside — they prompt the body's own pituitary to release more of its own. That signaling loop is the growth-hormone (GH) axis, and downstream of GH sits IGF-1, the mediator through which much of the anabolic and body-composition research is measured. Two distinct classes of compound push on that axis, from two different directions, which is exactly why they're interesting together.
Quick comparison
| Peptide | Class | Research focus |
|---|---|---|
| CJC-1295 | GHRH analog | Sustained GH / IGF-1 signaling |
| Tesamorelin | GHRH analog | Body composition, visceral fat |
| Ipamorelin | Ghrelin mimetic (GHRP) | Clean, selective GH pulse |
| BPC-157 | Repair peptide | Tissue repair & recovery |
GHRH analogs: CJC-1295 & Tesamorelin
The first class mimics growth-hormone-releasing hormone (GHRH) — the body's natural "release GH" signal to the pituitary. CJC-1295 is the one most studied for sustained GH and IGF-1 elevation, and it comes in a long-acting DAC form and a short-acting no-DAC form. Tesamorelin is the same class with a different research emphasis: its literature centers on visceral fat and body composition. Both raise GH by telling the pituitary to release it.
Ghrelin mimetics: Ipamorelin
The second class works on a different receptor entirely: the ghrelin receptor (GHS-R). Ipamorelin is the standout here because it's one of the most selective — it prompts a clean GH pulse without the cortisol and prolactin spillover of older secretagogues. Where GHRH analogs raise the amount of GH released, ghrelin mimetics amplify the pulse and ease off the body's own "brake" on GH. Two levers, two receptors.
The classic pairing — and why it works
This is why CJC-1295 and Ipamorelin are the single most common combination in GH-axis research. Because the two act on separate receptors, stimulating both at once produces a fuller, more complete GH response than doubling up on either one. It's the textbook example of complementary rather than redundant mechanisms — the same logic behind the BPC-157 / TB-500 pairing in recovery research, just applied to the growth-hormone axis.
Recovery support: BPC-157
BPC-157 isn't a growth-hormone compound, but it appears in this category for a practical reason: research into training and physical stress inevitably touches tissue repair and recovery, and BPC-157 is the most-studied peptide there. It's studied for localized repair and blood-vessel formation rather than muscle growth directly — a supporting role. We cover it fully in the healing & recovery guide.
Blends and combinations
Because the two secretagogue classes are complementary, they're frequently studied together — which is why the pre-mixed CJC-1295 / Ipamorelin blend exists, combining both in a single research vial. Whether single or blended, every compound arrives as freeze-dried powder that needs to be reconstituted and stored properly, and our peptide calculator handles the concentration math.
Browse the GH-axis lineup. Third-party tested, USA-sourced, with published COAs where available.
Shop Research PeptidesFrequently asked questions
Which peptides are most studied here? The growth-hormone secretagogues — GHRH analogs (CJC-1295, Tesamorelin) and ghrelin mimetics (Ipamorelin) — with BPC-157 for the recovery side.
Why are CJC-1295 and Ipamorelin studied together? They act on different receptors (GHRH and ghrelin), so together they generate a fuller GH response than either alone.
Does this describe a way to build muscle? No. This is a research-context overview of mechanisms only. The compounds are for laboratory research and are not approved for or intended for human use.
All Patriot Labs products are sold strictly for in-vitro research and laboratory use only. Not for human consumption. This guide describes research context and mechanisms in general terms; it is not medical advice, a training protocol, or a claim about outcomes in humans.